Safety and pharmacokinetics of rituximab in combination with FAB chemotherapy in children and adolescents with Stage III/IV mature B-NHL and B-cell leukemia ± CNS disease: a Children's Oncology Group Report

被引：0
|
作者：
Barth, M. J. [1 ]
Goldman, S. [2 ]
Zhi, J. [3 ]
Smith, L. [4 ]
Harrison, L. [5 ]
Perkins, S. L. [6 ]
Shiramizu, B. [7 ]
Gross, T. [6 ,8 ]
Sanger, W. [4 ]
Cairo, M. S. [5 ,9 ,10 ,11 ,12 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[2] Med City Childrens Hosp, Div Pediat Hematol Oncol, Dallas, TX USA
[3] Hoffmann La Roche Inc, Nutley, NJ 07110 USA
[4] Univ Nebraska, Coll Publ Hlth, Dept Biostat, Omaha, NE 68182 USA
[5] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA
[6] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[7] Univ Hawaii, Div Pediat Hematol Oncol, Honolulu, HI 96822 USA
[8] Ohio State Univ, Columbus, OH 43210 USA
[9] New York Med Coll, Dept Med, Valhalla, NY 10595 USA
[10] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA
[11] New York Med Coll, Dept Microbiol, Valhalla, NY 10595 USA
[12] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 159卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
40
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [21] Therapy of Advanced-stage Mature B-cell Lymphoma and Leukemia in Children and Adolescents With Rituximab and Reduced Intensity Induction Chemotherapy (B-NHL 2004M Protocol): The Results of a Multicenter Study
    Samochatova, Elena V.
    Maschan, Alexey A.
    Shelikhova, Larisa N.
    Myakova, Natalia V.
    Belogurova, Margarita B.
    Khlebnikova, Olga P.
    Shamardina, Anastasia V.
    Ryskal, Olga V.
    Roumiantseva, Julia V.
    Konovalov, Dmitriy M.
    Dubrovina, Maria E.
    Rumyantsev, Alexander G.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (05) : 395 - 401
  • [22] Treatment of acute lymphoblastic mature B-cell leukemia (B-NHL/ALL) in children and adolescents by intensive polychemotherapy and rituximab (NHL-2004m protocol): Pilot results
    Samochatova, E. V.
    Shelikhova, L. N.
    Myakova, N. V.
    Fechina, L. G.
    Belogurova, M. B.
    Inyushkina, E. V.
    Litvinov, D. V.
    Shamardina, A. V.
    Basharova, E. V.
    Ryskal, O. V.
    Abdullaev, R.
    Baidun, L. V.
    Plyasunova, S. A.
    Konovalov, D. M.
    Maschan, A. A.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2007, 52 (06): : 9 - 16
  • [23] Outcome of Relapse in Children/Adolescents with B-Cell Non-Hodgkin Lymphoma (B-NHL) and Mature Acute Leukemia (B-AL) Treated in the Rituximab (R) Era
    Rigaud, C.
    Auperin, A.
    Jourdain, A.
    Schmitt, C.
    Paillard, C.
    Couec, M. L.
    Aladjidi, N.
    Gandemer, V.
    Lambilliote, A.
    Plat, G.
    Michon, J.
    Leblanc, T.
    Patte, C.
    Minard-Colin, V.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S36 - S36
  • [24] Where is the place for rituximab in the treatment of B-cell non-Hodgkin lymphoma (B-NHL) of children and adolescents?
    Patte, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 110 - 110
  • [25] EXCELLENT OUTCOME IN CNS-POSITIVE PEDIATRIC BURKITT LYMPHOMA AND OTHER MATURE B-NHL TREATED WITH COMBINED CHEMO-IMMUNOTHERAPY (RITUXIMAB plus FAB GROUP C) WITHOUT CNS RADIATION: A CHILDREN'S ONCOLOGY GROUP REPORT
    Frazer, J. K.
    Goldman, S.
    Harrison, L.
    Perkins, S. L.
    Cairo, M. S.
    ANNALS OF ONCOLOGY, 2011, 22 : 177 - 177
  • [26] Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report
    Galardy, Paul J.
    Hochberg, Jessica
    Perkins, Sherrie L.
    Harrison, Lauren
    Goldman, Stanton
    Cairo, Mitchell S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (03) : 365 - 372
  • [27] Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy
    Gerrard, Mary
    Waxman, Ian M.
    Sposto, Richard
    Auperin, Anne
    Perkins, Sherrie L.
    Goldman, Stanton
    Harrison, Lauren
    Pinkerton, Ross
    McCarthy, Keith
    Raphael, Martine
    Patte, Catherine
    Cairo, Mitchell S.
    BLOOD, 2013, 121 (02) : 278 - 285
  • [28] Use of immunoglobulin heavy chain primer pools to assess minimal residual disease/persistent disease (MRD/PD) in children and adolescents with mature B-cell non-Hodgkin lymphoma (B-NHL): A Children's Oncology Group report.
    Shiramizu, B.
    Goldman, S.
    Kusao, I.
    Agsalda, M.
    Lynch, J. C.
    Harrison, L.
    Gross, T. G.
    Sanger, W.
    Perkins, S. L.
    Cairo, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report
    Shiramizu, Bruce
    Goldman, Stanton
    Kusao, Ian
    Agsalda, Melissa
    Lynch, James
    Smith, Lynette
    Harrison, Lauren
    Morris, Erin
    Gross, Thomas G.
    Sanger, Warren
    Perkins, Sherrie
    Cairo, Mitchell S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (06) : 758 - 763
  • [30] ISOLATED MYC REARRANGEMENT BY CYTOGENETICS/FISH IN CHILDREN AND ADOLESCENTS (C&A) WITH STAGE III/IV B-NHL BM+ AND/OR CNS+ MAY HAVE AN IMPROVED OUTCOMES FOLLOWING IMMUNOCHEMOTHERAPY: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
    Nelson, M.
    Goldman, S.
    Harrison, L.
    Cairo, M. S.
    Sanger, W.
    ANNALS OF ONCOLOGY, 2011, 22 : 175 - 175
12345